Lantheus Holdings, Inc. (LNTH) Stake Raised by Parametric Portfolio Associates LLC
Parametric Portfolio Associates LLC boosted its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) by 28.9% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 22,530 shares of the medical equipment provider’s stock after buying an additional 5,058 shares during the period. Parametric Portfolio Associates LLC owned approximately 0.06% of Lantheus Holdings worth $282,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. IFP Advisors Inc purchased a new stake in Lantheus Holdings during the first quarter valued at $231,000. Highbridge Capital Management LLC purchased a new stake in Lantheus Holdings during the fourth quarter valued at $237,000. Algert Global LLC purchased a new stake in Lantheus Holdings during the first quarter valued at $357,000. Bank of New York Mellon Corp boosted its stake in Lantheus Holdings by 6.3% in the first quarter. Bank of New York Mellon Corp now owns 68,473 shares of the medical equipment provider’s stock valued at $856,000 after buying an additional 4,084 shares during the period. Finally, Capital One National Association boosted its stake in Lantheus Holdings by 7.7% in the first quarter. Capital One National Association now owns 69,050 shares of the medical equipment provider’s stock valued at $863,000 after buying an additional 4,925 shares during the period. Institutional investors own 65.89% of the company’s stock.
Lantheus Holdings, Inc. (NASDAQ LNTH) opened at 17.20 on Friday. Lantheus Holdings, Inc. has a 52 week low of $3.46 and a 52 week high of $20.40. The company’s 50-day moving average is $17.48 and its 200 day moving average is $13.82. The company has a market capitalization of $642.42 million, a price-to-earnings ratio of 23.50 and a beta of 0.91.
Lantheus Holdings (NASDAQ:LNTH) last issued its quarterly earnings data on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.24 by $0.18. The business had revenue of $88.83 million for the quarter, compared to the consensus estimate of $80.56 million. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The company’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.24 EPS. On average, analysts forecast that Lantheus Holdings, Inc. will post $0.93 EPS for the current fiscal year.
Several equities research analysts have recently weighed in on the stock. Jefferies Group LLC reiterated a “buy” rating and set a $22.00 price objective (up from $18.00) on shares of Lantheus Holdings in a research report on Wednesday. Zacks Investment Research upgraded shares of Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 price objective for the company in a research report on Thursday, May 4th. Cantor Fitzgerald assumed coverage on shares of Lantheus Holdings in a research report on Monday, July 17th. They set an “overweight” rating and a $22.00 price objective for the company. Finally, Credit Suisse Group increased their price objective on shares of Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Lantheus Holdings presently has a consensus rating of “Buy” and an average target price of $18.60.
In other Lantheus Holdings news, Director David F. Burgstahler sold 3,000,000 shares of the business’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $14.87, for a total transaction of $44,610,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Mary Anne Heino sold 10,000 shares of the business’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $15.39, for a total transaction of $153,900.00. Following the transaction, the chief executive officer now directly owns 602,468 shares in the company, valued at $9,271,982.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,060,000 shares of company stock worth $85,757,800. Insiders own 2.30% of the company’s stock.
Lantheus Holdings Company Profile
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.